Live tape
Top 8, mentions 7d17,651MSFT3,329 mentions▲ +0.08GOOGL2,704 mentions▲ +0.05AAPL2,319 mentions▲ +0.07META2,240 mentions▲ +0.04SPCX1,997 mentions▲ +0.06SNDK1,870 mentions▲ +0.06NVDA1,760 mentions▲ +0.07QQQ1,432 mentions▲ +0.04

Equity · Healthcare

MMED

MiniMed Group, Inc. · NasdaqGS

$16.94 +6.74% 1D Finazon · prior-day close · Jul 17, 2026
Price · Chart Chart by TradingView
Track this symbol on TradingView

The chart above plots the price of MMED over the range selected — one day to the full history — drawn by TradingView from their own data. Our own licensed end-of-day series holds 55 sessions over that window: $12.10 on 1 May 2026 through $16.94 on 17 July 2026. Finazon · prior-day close.

Market cap $4.8B
52-week range $10.86 – $18.04
Avg volume 273.5K

Finazon · prior-day close · valuation computed from SEC EDGAR filings · as of Jul 29, 2026

MMED insider trades

SEC Form 4 · last 90 days · newest reported trade 28 Jul 2026
Open-market buys 0
Open-market sells 0
Non-trade filings 8
Compensation mechanics (8 filings)

Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.

Date Insider Type Shares Value
28 Jul 2026 Chandrasena Gillian SVP, Chief HR Officer Tax withheld 2,099 $37K
28 Jul 2026 Spooner Chad EVP, Chief Financial Officer Tax withheld 23,301 $412K
01 Jul 2026 Chandrasena Gillian SVP, Chief HR Officer Award 44,188
01 Jul 2026 Dallara Que Chief Executive Officer Award 297,618
01 Jul 2026 Dianaty Ali See Remarks Award 131,312
01 Jul 2026 Gyurci John VP, Chief Accounting Officer Award 24,244
01 Jul 2026 Wills Courtney Nelson SVP, Gen. Counsel, Corp. Sec. Award 82,787
01 Jul 2026 Spooner Chad EVP, Chief Financial Officer Award 116,607

MMED reported financials

SEC EDGAR XBRL

MMED reported revenue of $3.1B for the fiscal year ended 24 Apr 2026. Net income over the same period was −$333.0M.

Figure Reported Period
Revenue $3.1B 24 Apr 2026 fiscal year
Net income −$333.0M 24 Apr 2026 fiscal year
Diluted EPS −$1.30 24 Apr 2026 fiscal year
Total assets $4.6B 24 Apr 2026 at period end
Total equity $3.6B 24 Apr 2026 at period end

Source: SEC EDGAR XBRL company facts · latest period ended 24 Apr 2026

MMED earnings

SEC EDGAR
Date Period EPS Revenue
24 Apr 2026 FY 2026 $-1.30 $3.10B
23 Jan 2026 Q3 2026 $-0.47 $790M
25 Apr 2025 FY 2026 $-0.84 $2.72B
24 Jan 2025 Q3 2026 $-0.04 $687M

Reported figures & scheduled dates · SEC EDGAR filings

MMED institutional holders

SEC Form 13F

7 of the 45 institutional funds we track reported a MMED position for the quarter ended 31 Mar 2026 — a combined $118.2M; the latest of those filings landed 15 May 2026.

Fund Action Shares Value
Citadel Advisors New position 2,851,539 $42.5M
Millennium Management New position 2,593,434 $38.7M
Point72 Asset Management New position 1,139,793 $17.0M
Balyasny Asset Management New position 854,748 $12.8M
D. E. Shaw & Co. New position 450,000 $6.7M
Two Sigma Investments New position 16,265 $243K
Tudor Investment Corp New position 15,900 $237K

Source: SEC EDGAR 13F filings

MMED fails-to-deliver

SEC CNS data

On 29 Jun 2026, 4,965 shares of MMED failed to deliver (about $71K).

Settlement date Shares failed Notional % of shares out
29 Jun 2026 4,965 $71K 0.002%
22 Jun 2026 300 $4K <0.001%
16 Jun 2026 680 $10K <0.001%
15 Jun 2026 531 $8K <0.001%

Source: SEC fails-to-deliver (CNS) data